RAPT Therapeutics Inc.
Chart
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer
About RAPT Therapeutics Inc.
RAPT Therapeutics Inc is a clinical-stage immunology-based biopharmaceutical company. It is focused on discovering, developing, and commercializing oral small-molecule therapies for patients with some unmet needs in oncology and inflammatory diseases. The company pipeline products include FLX475, designed to selectively inhibit the migration of immunosuppressive regulatory T cells into tumors; and RPT193, designed to selectively inhibit the migration of type 2 T helper cells into inflamed tissues.
/ 
Frequently asked questions
To buy RAPT Therapeutics Inc. stock, open a Saxo account and fund it. With SaxoInvestor or SaxoTrader, you can easily search for RAPT Therapeutics Inc. by name or ticker, choose the number of shares, and place your order.
The ticker symbol for RAPT Therapeutics Inc. is RAPT:xnas. You can use this code to quickly find the stock in Saxo’s platforms and track its price and performance.
RAPT Therapeutics Inc. has its primary listing on NASDAQ. You can trade RAPT Therapeutics Inc. with a Saxo account, alongside thousands of other stocks worldwide.
Yes, RAPT Therapeutics Inc. is available to trade on SaxoInvestor and SaxoTraderGO. You can buy shares directly and include RAPT Therapeutics Inc. as part of a broader investment portfolio. Explore our SaxoInvestor platform.
Learn more about investing and trading at Saxo’s educational content hub. Explore portfolio strategies, types of stocks, diversification, and valuation measures— so you can make more informed decisions when considering shares like RAPT Therapeutics Inc..